No Detail Found!

Angiotensin-converting enzyme inhibitors; their efficacy, adverse effects, and the genetic influence on cough they may cause

Author(s)
Arooj Fatima Sheikh Shifa College of Pharmaceutical Sciences, Shifa Tamer-e-Millat University Islamabad,,Pakistan
Fatima Siraj Memon Shifa College of Pharmaceutical Sciences, Shifa Tamer-e-Millat University Islamabad,,Pakistan
Najam Ul Sahar Shifa Plus Pharmacy,Bahria Town Rawalpindi,Pakistan
Abstract
Hypertension is a significant health condition that increases the risk of several other diseases, including renal failure, myocardial infarction, stroke, and death. Angiotensin-converting enzyme inhibitors (ACE-Is) are part of most protocols used to manage hypertension and various other conditions, including congestive heart failure and myocardial infarction. Even though these therapies are well tolerated, one in every five individuals discontinues them due to adverse medication reactions, the most prevalent of which is a persistent dry cough. Heritability accounts for 30% to 50% of inter-individual variation in blood pressure. However, the genetic variation connected to ACE-I-induced cough remains contentious and requires additional investigation. In addition, genetic variation may affect the incidence of ACE-I-related cough. This article examines ACE-Is' efficacy, their adverse effects, and pharmacogenetic studies on ACE-I-induced cough.
Publication Details
Page(s) 77-88
Published Journal: Molecular Medicine Communications, Volume: 2, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Hypertension, Cough, Genetic polymorphisms, angiotensin-converting enzyme inhibitors
0

Citations

0

Downloads

46

Views